Multi-peptide blend (GHK-Cu 50mg / BPC-157 10mg / TB-500 10mg), lyophilised powder for laboratory research into combined peptide signalling pathways
PMID 26497402
AOD-9604, a modified growth hormone fragment, directly stimulates fat breakdown (lipolysis) and inhibits new fat formation without affecting growth or insulin sensitivity, offering a more direct fat reduction approach
As with any therapy, long-term studies are still limited, so ongoing observation and clinical research will further define its safety profile
Ingredients Bulking agent cellulose, L-glutathione reduced, carriers calcium phosphate and cross-linked sodium carboxymethyl cellulose, lactose monohydrate, pomegranate peel extract (Punica L.), superoxide dismutase, maltodextrin, milk thistle seed extract (Silybum marianum L.), L-cysteine, anti-caking agents magnesium salts of fatty acids and silicon dioxide, glazing agent (neutral methacrylate copolymer, talc, propylene glycol, colorant carmine)